C3.ai vs. UiPath: Which Artificial Intelligence Stock Is a Better Investment in 2026?

As the race for enterprise AI automation intensifies, investors are weighing different paths to potential profit. Is the pure-play approach of C3.ai (NYSE:AI) or the orchestration power of UiPath (NYSE:PATH) the better buy?

C3.ai provides ready-to-use artificial intelligence applications for government and industrial sectors, while UiPath focuses on automating repetitive workflow tasks through its AI software. Both companies represent different segments of the modern intelligence revolution. They compete for corporate budgets as businesses modernize their workflows, making a direct comparison essential for investors.

The case for C3.ai

C3.ai sells enterprise-grade software applications that help organizations deploy predictive analytics and generative AI at scale. As businesses evaluate tech stocks for their next digital transformation cycle, the company targets sectors like defense, manufacturing, and oil and gas. It has historically relied on high-value partners like Baker Hughes, though it is currently transitioning toward a consumption-based pricing model to attract smaller customers.

In its 2026 fiscal year (FY) ended April 30, revenue reached $250.3 million, which represented a decrease of 35.7% compared to the prior year. The company reported a net loss of $470.4 million during this period, resulting in a net margin of negative 187.9%. This negative net margin indicates that for every dollar of revenue generated, the company lost nearly two dollars after accounting for all expenses.

As of its April 2026 balance sheet, the current ratio is 6.6x. This current ratio measures assets that can be converted to cash within a year against liabilities due in that same period, indicating a strong liquidity position. The company carries a debt-to-equity ratio of zero, which measures total debt against shareholder equity, while free cash flow reached a loss of $190.7 million. Free cash flow is the cash a company generates after accounting for cash outflows to support its operations and capital assets.

The case for UiPath

UiPath provides an end-to-end platform that combines robotic process automation with new AI agents to orchestrate complex business processes. The company serves thousands of customers globally, including a significant number of large organizations that contribute more than $1 million in annual recurring revenue.

In FY 2026 ended Jan. 31, revenue reached $1.6 billion, representing growth of 13% over the previous fiscal year. The company achieved net income of $282.3 million, yielding a net margin of 17.5%. This positive net margin shows that the company successfully converted a portion of its sales into profit after covering all operating and non-operating costs.

As of its January 2026 balance sheet, the current ratio is 2.5x. The company maintains a debt-to-equity ratio of zero, showing it has no significant borrowed money relative to its equity base. Free cash flow reached $352.2 million for the year. Note that stock-based compensation (SBC) represented 78.3% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.

Risk profile comparison

C3.ai faces significant risks related to its customer concentration and its ongoing transition to a consumption-based sales model. The company must navigate intense competition in the AI arena. Additionally, evolving global regulations like the EU AI Act could increase compliance costs, while past legal scrutiny remains a point of focus for cautious investors.

UiPath also contends with customer concentration, as a small percentage of its largest clients accounts for a substantial portion of its total revenue. The company is vulnerable to service interruptions from the third-party cloud infrastructure providers it relies on to deliver products. Furthermore, it faces the challenge of managing rapid organizational growth and integrating recent acquisitions while competing against established software firms like Microsoft.

Valuation comparison

UiPath appears more attractively valued than its peer in this comparison, carrying a lower multiple on annual sales. C3.ai lacks a forward P/E ratio since it is unprofitable, and not expected to achieve profitability in the near term.

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

Although C3.ai and UiPath both operate in the hot field of artificial intelligence, the one I would invest in is the latter. C3.ai's business was doing well until CEO Thomas Siebel resigned from the position due to health issues. That's when the company's sales declined, and although Siebel returned to the CEO role in June, it will take time for C3.ai to rebound.

UiPath's business is expanding. Its fiscal 2026 sales growth of 13% was solid, and that percentage has accelerated to a 17% year-over-year increase to $418 million in its fiscal first quarter ended April 30.

UiPath forecasted fiscal 2027 full-year revenue to hit about $1.8 billion, up from the prior year's $1.6 billion. C3.ai expects another year of falling sales, with fiscal 2027 guidance between $210 million and $240 million compared to $250.3 million in fiscal 2026.

In addition, UiPath boasts stronger financial health. While C3.ai is not a profitable company, UiPath reported fiscal Q1 net income of $22.5 million.

Robert Izquierdo has positions in C3.ai, Microsoft, and UiPath. The Motley Fool has positions in and recommends Microsoft and UiPath. The Motley Fool recommends C3.ai. The Motley Fool has a disclosure policy.